AtriCure, Inc. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
AtriCure, Inc. (ATRC) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $4.77 million as of 2026-06-30, per its 10-Q filed 2026-07-27.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-07-27
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $4.77M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $7.15M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $2.11M.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $4.22M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $4.77M 10-Q · filed 2026-07-27 |
| 2026-03-31 | $7.15M 10-Q · filed 2026-05-06 |
| 2025-09-30 | $2.11M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $4.22M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $6.33M 10-Q · filed 2025-04-30 |
| 2024-09-30 | $1.89M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $3.77M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $5.59M 10-Q · filed 2024-05-02 |
| 2023-09-30 | $1.70M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $3.40M 10-Q · filed 2023-07-26 |
| 2023-03-31 | $2.21M 10-Q · filed 2023-05-03 |
| 2022-09-30 | $739.00K 10-Q · filed 2022-11-02 |
| 2022-06-30 | $1.71M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $2.68M 10-Q · filed 2022-05-04 |
| 2021-09-30 | $972.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.94M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $713.00K 10-Q · filed 2021-04-28 |
| 2020-09-30 | $378.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $845.00K 10-Q · filed 2020-07-29 |
| 2020-03-31 | $1.33M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $1.82M 10-K · filed 2020-02-24 |
| 2019-09-30 | $489.00K 10-Q · filed 2019-10-31 |
| 2019-06-30 | $968.00K 10-Q · filed 2019-07-31 |
| 2019-03-31 | $1.45M 10-Q · filed 2019-04-26 |
| 2018-12-31 | $1.94M 10-K · filed 2019-03-01 |
| 2018-09-30 | $342.00K 10-Q · filed 2018-11-02 |
| 2018-06-30 | $683.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $1.02M 10-Q · filed 2018-04-27 |
| 2017-12-31 | $1.37M 10-K · filed 2018-02-28 |
| 2017-09-30 | $341.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $683.00K 10-Q · filed 2017-07-28 |
| 2017-03-31 | $1.02M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $1.37M 10-K · filed 2017-03-08 |
| 2016-09-30 | $411.00K 10-Q · filed 2016-10-28 |
| 2016-06-30 | $822.00K 10-Q · filed 2016-08-05 |
| 2016-03-31 | $1.23M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $1.64M 10-K · filed 2016-02-29 |
| 2015-09-30 | $300.00K 10-Q · filed 2015-10-30 |
| 2015-06-30 | $602.00K 10-Q · filed 2015-07-31 |
| 2015-03-31 | $905.00K 10-Q · filed 2015-05-01 |
| 2014-12-31 | $1.21M 10-K · filed 2015-03-02 |
| 2014-09-30 | $355.00K 10-Q · filed 2014-10-31 |
| 2014-06-30 | $710.00K 10-Q · filed 2014-07-30 |
| 2014-03-31 | $1.07M 10-Q · filed 2014-04-30 |
| 2013-09-30 | $4.00K 10-Q · filed 2013-11-01 |
| 2012-09-30 | $3.00K 10-Q · filed 2012-11-02 |
| 2012-06-30 | $6.00K 10-Q · filed 2012-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |